Aurelia Rughetti

13.4k total citations · 2 hit papers
81 papers, 1.9k citations indexed

About

Aurelia Rughetti is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Aurelia Rughetti has authored 81 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 35 papers in Molecular Biology and 28 papers in Oncology. Recurrent topics in Aurelia Rughetti's work include Immunotherapy and Immune Responses (33 papers), Glycosylation and Glycoproteins Research (20 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Aurelia Rughetti is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), Glycosylation and Glycoproteins Research (20 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Aurelia Rughetti collaborates with scholars based in Italy, United States and United Kingdom. Aurelia Rughetti's co-authors include Marianna Nuti, Chiara Napoletano, Ilaria Grazia Zizzari, Hassan Rahimi, Luigi Frati, Filippo Bellati, Pierluigi Benedetti Panici, Joyce Taylor‐Papadimitriou, Fabio Scirocchi and Andrea Botticelli and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Aurelia Rughetti

72 papers receiving 1.9k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma

2024 142 citations Alessandra De Leo, Alessio Ugolini et al. profile →
Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation

2025 23 citations Alessio Ugolini, Alessandra De Leo et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aurelia Rughetti Italy	27	1.0k	954	622	312	206	81	1.9k
Anda Vlad United States	25	1.0k 1.0×	989 1.0×	629 1.0×	272 0.9×	270 1.3×	53	2.0k
Keiko Udaka Japan	29	1.4k 1.4×	1.5k 1.5×	612 1.0×	388 1.2×	70 0.3×	65	2.6k
S. V. Litvinov Netherlands	18	629 0.6×	1.3k 1.4×	980 1.6×	648 2.1×	262 1.3×	28	2.4k
Mark S. Singer United States	22	1.6k 1.6×	1.7k 1.8×	393 0.6×	469 1.5×	292 1.4×	33	3.4k
Ilaria Grazia Zizzari Italy	25	782 0.8×	663 0.7×	1.1k 1.7×	99 0.3×	185 0.9×	61	1.9k
Max Dobles United States	9	1.4k 1.4×	1.3k 1.3×	580 0.9×	218 0.7×	387 1.9×	10	2.9k
Josef Mysliwietz Germany	18	478 0.5×	636 0.7×	540 0.9×	199 0.6×	212 1.0×	47	1.7k
Christian‐Jacques Larsen France	30	496 0.5×	1.6k 1.7×	819 1.3×	180 0.6×	268 1.3×	107	2.6k
Ulrich Brinck Germany	23	303 0.3×	812 0.9×	478 0.8×	239 0.8×	204 1.0×	98	1.6k
Gundram Jung Germany	31	1.7k 1.6×	871 0.9×	1.4k 2.3×	729 2.3×	193 0.9×	114	2.9k

Countries citing papers authored by Aurelia Rughetti

Since Specialization

Citations

This map shows the geographic impact of Aurelia Rughetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurelia Rughetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurelia Rughetti more than expected).

Fields of papers citing papers by Aurelia Rughetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurelia Rughetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurelia Rughetti. The network helps show where Aurelia Rughetti may publish in the future.

Co-authorship network of co-authors of Aurelia Rughetti

This figure shows the co-authorship network connecting the top 25 collaborators of Aurelia Rughetti. A scholar is included among the top collaborators of Aurelia Rughetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurelia Rughetti. Aurelia Rughetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Besharat, Zein Mersini, Fabrizio Mainiero, Aurelia Rughetti, et al.. (2025). MiR-326: Role and significance in brain cancers. Non-coding RNA Research. 12. 56–64.

Ugolini, Alessio, Alessandra De Leo, Xiaoqing Yu, et al.. (2025). Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation. Cancer Discovery. 15(6). 1270–1296. 23 indexed citations breakdown →

Gelibter, Alain, Lidia Strigari, Ilaria Grazia Zizzari, et al.. (2024). CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line. Journal of Translational Medicine. 22(1). 329–329. 7 indexed citations

Currà, Antonio, Patrizia Gargiulo, Aurelia Rughetti, et al.. (2024). Frequency of brain ventricular enlargement among patients with diabetes mellitus. Diabetes Research and Clinical Practice. 210. 111644–111644.

Filetti, Marco, Mario Occhipinti, Alessio Cirillo, et al.. (2024). Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature. Cancers. 16(23). 3955–3955. 1 indexed citations

Ceccarelli, Fulvia, Francesco Natalucci, G. Olivieri, et al.. (2023). Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity. Journal of Immunology Research. 2023. 1–6. 3 indexed citations

Mezi, Silvia, Giulia Pomati, Giulia Fiscon, et al.. (2023). A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors. Frontiers in Immunology. 14. 1199089–1199089.

Cirillo, Alessio, Ilaria Grazia Zizzari, Andrea Botticelli, et al.. (2023). Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients. International Journal of Molecular Sciences. 24(8). 7114–7114. 9 indexed citations

Zizzari, Ilaria Grazia, Andrea Botticelli, Lidia Strigari, et al.. (2022). Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer. Clinical Cancer Research. 28(5). 1027–1037. 21 indexed citations

10.

Napoletano, Chiara, Zilu Ye, Hassan Rahimi, et al.. (2020). Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-Type Lectin (MGL). Cancers. 12(10). 2841–2841. 14 indexed citations

11.

Napoletano, Chiara, Ilary Ruscito, Filippo Bellati, et al.. (2019). Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets. Journal of Clinical Medicine. 8(3). 380–380. 29 indexed citations

12.

Zizzari, Ilaria Grazia, Chiara Napoletano, Andrea Botticelli, et al.. (2018). TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway. Cancer Immunology Research. 6(6). 711–722. 51 indexed citations

13.

Ruscito, Ilary, Silvia Darb‐Esfahani, Hagen Kulbe, et al.. (2018). The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis. Gynecologic Oncology. 150(1). 151–157. 24 indexed citations

14.

Napoletano, Chiara, Simonetta Mattiucci, Alessandra Colantoni, et al.. (2018). Anisakis pegreffii impacts differentiation and function of human dendritic cells. Parasite Immunology. 40(5). e12527–e12527. 22 indexed citations

15.

Rughetti, Aurelia, Hassan Rahimi, Francesca Belleudi, et al.. (2013). Microvesicle Cargo of Tumor-Associated MUC1 to Dendritic Cells Allows Cross-presentation and Specific Carbohydrate Processing. Cancer Immunology Research. 2(2). 177–186. 28 indexed citations

16.

Zizzari, Ilaria Grazia, Filippo Veglia, Hassan Rahimi, et al.. (2011). HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy. Journal of Molecular Medicine. 89(12). 1231–1240. 12 indexed citations

17.

Napoletano, Chiara, Aurelia Rughetti, Dora Pinto, et al.. (2009). Immunogenicity of Allo-Vesicle Carrying ERBB2 Tumor Antigen for Dendritic Cell-Based Anti-Tumor Immunotherapy. International Journal of Immunopathology and Pharmacology. 22(3). 647–658. 27 indexed citations

18.

Rughetti, Aurelia, Ilenia Pellicciotta, Mauro Biffoni, et al.. (2005). Recombinant Tumor-Associated MUC1 Glycoprotein Impairs the Differentiation and Function of Dendritic Cells. The Journal of Immunology. 174(12). 7764–7772. 71 indexed citations

19.

Rughetti, Aurelia, Hassan Rahimi, P Rossi, et al.. (2003). Modulation of blood circulating immune cells by radiofrequency tumor ablation.. PubMed. 22(2). 247–50. 21 indexed citations

20.

Fattorossi, Andrea, Alessandra Battaglia, Luca Pierelli, et al.. (2001). Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation. Cancer Immunology Immunotherapy. 49(12). 641–648. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact